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Expanding the range of herbal drugs is among the priorities of the modern pharmacy. The analysis 
presented in this article is drawn from a broader qualitative study examining the composition of 
Anemone nemorosa L. chloroform fraction. The study revealed 38 compounds, and 32 of them were 
identified. The investigated lipophilic extract has an antimicrobial activity both in terms of gram-
positive and gram-negative microorganisms. The maximal antimicrobial action of the investigated 
extract was shown to Escherichia coli. The significant content of biologically active substances in 
the lipophilic volatile fraction of Anemone nemorosa indicates the prospects for further study. 
________________________________________________________________________________ 
Introduction 
In recent years, there has been observed 
an increasing interest in medicinal herbs [1]. This 
indicates a need to understand the various aspects 
of making and producing new phyto-remedies 
and introducing them into practical use. 
Anemone nemorosa L. is a herbaceous perennial 
plant of the buttercup Ranunculaceae family [2-
4]. The plant is considered unofficinal, though it 
is widely used in folk medicine as an antitumor, 
sedative, bactericidal, antimicrobial, antifungal, 
anti-inflammatory, spasmolytic diaphoretic, 
expectorant, and diuretic drug [5-11]. The major 
biologically active substances in Anemone 
nemorosa are: alkaloids, glycosides (proto-
anemonin, anemonin, ranunculin, some types of 
saponins, tannins), vitamin C, resins, organic 
acids (chelidonic acid), coumarins, flavonoids, 
and γ-Linolenic acid [12-15].  
Evidence suggests that this herb is 
referred to as a regionally rare plant of 
administrative territories of Ukraine [16-17]. 
Taking into account the wide experience of its 
use in folk medicine [18], a wide spectrum of 
pharmacological activity, the content of valuable 
biologically active compounds [7], as well as the 
results of phytochemical and pharmacological 
studies, it becomes clear that the further use of 
Anemone nemorosa as a valuable medicinal plant 
material is an urgent task of pharmacy and 
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pharmaceutical biotechnology in view of the 
prospects of scientific research on development 
and introduction into production of new phyto-
remedies.  
At present, we carry out a systematic 
study of lipophilic compounds. The main 
objective of this study is to investigate and 
determine the component composition of the 
chloroform fraction of Anemone nemorosa and 
study of its antimicrobial properties. 
Experimental part 
Material and methods 
The object of the study was herb of 
Anemone nemorosa L. that was collected in 2018 
in an ecologically clean region of the Carpathians 
(Ivano-Frankivsk region, Ukraine), and the 
lipophilic extract of Anemone nemorosa L. The 
shade-dried aerial parts were powdered and 
extracted with the chloroform using a Soxhlet 
extractor, then the solvent was removed in vacuo 
until dry extract. 
Analysis of biologically active substances 
of the lipophilic fraction was performed using 
chromatograph Agilent Technology 6890 GC 
System with mass spectrometry detector 
HP 5973 Mass Selective Detector. The 
components were separated in a fused silica 
column Restek Rtx-5MS being 30 m long and 
having an internal diameter of 0.32 mm. The 
stationary liquid phase was 0.25 μm thick and 
consisted of 95% of polymethylsiloxane and 5% 
of phenylpolysiloxane. The carrier gas was 
helium. The velocity of the carrier gas was 
2.0 ml/min. The thermostat of the column was 
heated in such a program: the initial temperature 
of 60°C was maintained for 10 minutes, and then 
the temperature was increased with the tempo of 
20°C/min to 280°C. This temperature remained 
constant for 30 min, the temperature of the 
detector and the evaporator was 280°C. 
Biologically active substances were identified by 
their retention time, comparing it with standards 
and with the library of mass spectra NIST 05 and 
WILEY 2007, the total number of spectra being 
more than 470000. 
Antibacterial and antifungal bioassay 
Four Gram-negative bacteria (reference 
strains Pseudomonas aeruginosa (ATCC 27853 
(F-51)), Escherichia coli (ATCC 25922) and 
clinical multi-drug resistance (MDR, according 
to [19]) strains Pseudomonas aeruginosa, 
Escherichia coli), five Gram-positive bacteria 
(reference strains Staphylococcus aureus 
(ATCC 25923 (F-49)), Staphylococcus 
epidermidis (191), Bacillus licheniformis 
(VKPM-7038) and clinical MDR strains 
Staphylococcus aureus and methicillin-resistant 
Staphylococcus aureus (MRSA)), and four strain 
of yeast (reference strains Candida albicans 
(ATCC 885-653), Candida albicans (ATCC 
668-853) and clinical MDR strain 
Candida dubliniensis and Candida albicans 
resistant to nistatin sensitive to itraconazole and 
fluconazole) were used for antibacterial and 
antifungul activity (disc diffusion and serial 
dilutions assay). 
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Table 1. Antibacterial and antifungul activity of chloroform fraction of Anemone nemorosa L. 
№ Tipe of species Species of bacteria and fungi 
Diameter of inhibitory zones (mm ± SD) 
Minimum 
Inhibitory (MIC) and 
Bactericidal /Fungicidal 
Concentration (MBC/MFC) 
Extract of 
Anemone 
nemorosa 
DMSO Water Ampicilin (10 mcg) 
Itraconazole 
(10 mcg) 
MIC 
(μg/mL) 
MBC /MFC 
(μg/mL) 
1 Gram-
negative 
bacteria 
reference 
strains 
Pseudomonas aeruginosa 
(ATCC 27853 (F-51)) 7.2 ± 0.3 6.8 ± 0.2 NA NA NA NT NT 
2 Escherichia coli 
(ATCC 25922) 14.2 ± 0.4 8.0 ± 0.4 NA 15.2 ± 0.4 NA 250 500 
3 clinical 
strains 
Pseudomonas aeruginosa (n=4) NA NA NA NA NA NT NT 
4 Escherichia coli (n=4) NA 6.4 ± 0.2 NA 7.4 ± 0.2 NA NT NT 
5 Gram-
positive 
bacteria 
reference 
strains 
Staphylococcus aureus 
(ATCC 25923 (F-49)) 10.2 ± 0.8 7.3 ±0 .3 NA 18.2 ± 0.8 NA NT NT 
6 Staphylococcus epidermidis 
(191) 9.4 ± 0.6 7.4 ± 0.2 NA 19.4 ± 0.5 NA 250 500 
7 Bacillus licheniformis 
(ВКПМ-7038) 11.5 ± 0.3 7.2 ± 0.4 NA 18.8 ± 0.6 NA NT NT 
8 clinical 
strains 
Staphylococcus aureus (n=4) 9.1 ± 0.6 7.2 ± 0.2 NA 12.2 ± 0.4 NA NT NT 
9 MRSA (n=4) NA NA NA NA NA NT NT 
10 Fungi reference 
strains 
Candida. albicans 
(ATCC 885-653) 10.3 ± 0.5 8.0 ± 0.2 NA NA 15.4 ± 0.6 250 500 
11 Candida albicans 
(ATCC 668-853) 10.2 ± 0.3 8.0 ± 0.2 NA NA 16.2 ± 0.2 NT NT 
12 clinical 
strains 
Candida dubliniensis (n=4) 6.6 ± 0.2 NA NA NA NA NT NT 
13 Candida albicans (n=4) 8.0 ± 0.7 7.0 ± 0.3 NA NA 7.6 ± 0.4 500 1000 
NA: no activity; NT: Not Tested; diameter of zone of inhibition (mm) including the disc diameter of 6 mm; data are presented as mean ±SD (n = 3). 
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After adjusting turbidity of each broth culiture of 
bacteria with saline (0.5 McFarland), inoculation 
of Mueller Hinton and Sabouraud agar plates was 
performed by using cotton swabs (6 mm 
diameter and containing 0.2 µm of extract). 
Results and discussion 
The first set of analyses examined the 
chromatogram of the extracts under study 
(Figure 1). 
Figure 1 and Table 2 show the results 
obtained. In the result of the study, the 
quantitative content of 38 volatile compounds 
was established, 32 of which were identified 
(Figure 1 and Table 2). 
Table 2. Identified compounds of Anemone nemorosa L. 
chloroform fraction 
№ Retention 
time 
Substance Content
% 
1 6.659 Caprylic aldehyde 0.17 
2 7.317 Limonene 0.52 
3 8.231 4-Ethyldacane 0.41 
4 14.562 7-n-Tripropyldecan 0.47 
5 14.791 Icosane 0.18 
6 15.134 Pentadecane 0.15 
7 15,691 2,3,6-Trimethyl-4-
octene 
0.12 
8 18.020 2-Methylpenta-
decane 
0.22 
9 19.249 2-Methyltricosane 0.32 
10 20.050 Heneicosane 0.44 
11 20.593 2,4-bis(1,1-
dibutyl)phenol 
0.60 
12 23.579 Heptadecane 0.19 
13 24,122 Tetracosane 0.21 
14 24.894 Heneicosane 0.52 
15 27.724 11-(1-Ethylpropyl)-
Heneicosane 
0.24 
16 29,224 Tetracosane 0.36 
17 29.967 Pentacosane 0.32 
18 30.453 Etyl palmitate 1.23 
19 32.582 Ethyl linoleate 0.88 
20 32.711 Dibutyl Sebacate 6.11 
21 32.954 Stearyl Alcohol 0.77 
22 33.411 Fumaric acid 2,2-
dicloroethyl 
tridecyl ester  
0.25 
23 33.726 Acetyltributyl 
citrate 
31.21 
24 34.626 Oleamide 
methylate 
0.55 
25 34.726 Oleamide  1.28 
26 35.712 Dibutyl Sebacate 0.33 
27 36.155 Dioctyl Sebacate 0.83 
28 36.612 Heneicosane 0.54 
29 38.170 Decyl octyl adipate 0.79 
30 38.699 Oleamide 1.26 
31 40.542 Docosane 0.39 
32 46.030 Pelargonic acid 
tridecyl ester 
1.15 
33 46.173 2,4-Difluoro-
benzoic acid 
nonadecyl ester 
3.47 
34 48.145 Rimuene 2.81 
35 48.388 Pyridine-3-
carboxamide 
2.54 
36 48.545 1,5-Dimethyl-
benzacridine 
0.78 
37 48.774 Loxapine 1.92 
38 48.916 Metoxyacetic acid 
heptadecil ester 
1.19 
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Figure 1. Chromatogram of volatile compounds of the Anemone nemorosa L. chloroform fraction
As it can be seen from these data, in the 
study of the component composition of the 
Anemone nemorosa chloroform fraction, 32 
compounds were identified, they being paraffinic 
hydrocarbons, esters, fatty aldehydes and 
terpenes. 
Further analysis showed that the 
dominant component in the sample was 
Acetyltributyl citrate – 31,21%. Among others, 
there were Oleamide – 3,09%, Loxapine – 
1,92%. The identified esters were: Dibutyl 
sebacate – 6,44%, 2,4-Difluorobenzoic acid 
nonadecyl ester – 3,47%, Metoxyacetic acid 
heptadecil ester – 1,19%, Pelargonic acid tridecyl 
ester – 1,15%. The following alkanes were 
present: Heneicosane – 1,5%, Tetracosane – 
0,53%, Docosane – 0,39%. Terpenes in the 
sample were presented by Monocyclic 
monoterpenes limonene – 0,52% and Diterpene 
rimuene – 2,81%. 
The results obtained of the study 
biological activity of Anemone nemorosa 
chloroform fraction suggest that the lipophilic 
extract under study has antimicrobial and 
antifungal activity against referece and clinical 
MDR strains Gramm-positive bacteria and fungi. 
The maximal antimicrobial action of the 
investigated extract was shown in relation to 
E. coli. When applying the method of serial 
dilutions, it was found that the maximum 
bactericidal effect of the tested extract was 
expressed relative to E. coli in dilution 1:4. 
Conclusions 
This study set out to analyse the 
composition of Anemone nemorosa chloroform 
fraction. The Anemone nemorosa lipophilic 
fraction was obtained using the method of 
exhaustive extraction with chloroform in the 
Soxhlet extractor. The yield was 6,93 %. 
Using chromatography–mass spectro-
metry, the component composition of the volatile 
matter of the Anemone nemorosa chloroform 
fraction was obtained for the first time. 
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38 substances were discovered, with 32 of them 
being identified.  
This study has shown that the 
Anemone nemorosa lipophilic extraction has an 
antimicrobial action on reference and clinical 
MDR strains of both gram-positive, gram-
negative microorganisms and Candida spp. The 
maximal antimicrobial action of the investigated 
extract was shown in relation to E. coli. 
One of the more important findings to 
emerge from this study is that the significant 
content of biologically active substances in the 
Anemone nemorosa lipophilic volatile fraction 
indicates the prospect of their further study in 
order to create new medicinal products. 
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